Advertisement

Topics

Probi AB Company Profile

21:31 EST 19th January 2019 | BioPortfolio

Probi is a biotech company that develops and patents probiotic strains for use in nutritional products.

Location

Lund
SE - 223 70
Sweden

Contact

Phone: 46 (0)46 286 89 20
Fax: 46 (0)46 286 89 28
Email: probi@probi.se


News Articles [10 Associated News Articles listed on BioPortfolio]

Ny vd för Probi

Tom Rönnlund blir vd för probiotika-bolaget.

Ny finanschef till Probi

Henrik Lundkvist blir ny CFO på probiotikabolaget.

Probi AB PROB Financial and Strategic SWOT Analysis Review [Report Updated: 08082018] Prices from USD $125

Probi AB PROB Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to b...

Probi AB PROB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryProbi AB Probi is a biotechnology company develops, produces and markets probiotics. The company offers licenses for its technology and sells finished products in bulk. It focuses on products f...

Probi AB PROB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryProbi AB Probi is a biotechnology company develops, produces and markets probiotics. The company offers licenses for its technology and sells finished products in bulk. It focuses on products f...

Probi AB PROB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25042018] Prices from USD $250

SummaryProbi AB Probi is a biotechnology company which develops, produces and markets probiotics. The company offers licenses for its technology and sells finished products in bulk. It focuses on prod...

Navamedic ASA: Tom Rönnlund to step down as CEO

Oslo, Oct 1, 2018 - Navamedic ASA (OSE: NAVA) today announces that Tom Rönnlund has tendered his resignation as CEO of Navamedic ASA and will leave the company at the end of 2018 to take up a...

Global and Asia Lactobacillus Paracasei Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Preoperative Breast Irradiation

The PROBI is a phase I/II trial assessing the feasibility of preoperative whole breast irradiation in female patients with low to intermediate risk breast cancer, who undergo breast conser...

Companies [1 Associated Companies listed on BioPortfolio]

Probi AB

Probi is a biotech company that develops and patents probiotic strains for use in nutritional products.

More Information about "Probi AB" on BioPortfolio

We have published hundreds of Probi AB news stories on BioPortfolio along with dozens of Probi AB Clinical Trials and PubMed Articles about Probi AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Probi AB Companies in our database. You can also find out about relevant Probi AB Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record